AI
DRUG
AdvisorShares Investments’s Bright Minds Biosciences DRUG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Buy |
14,481
+3,200
| +28% | +$83.6K | 0.07% | 195 |
|
|
2025
Q1 | $407K | Buy |
11,281
+8,206
| +267% | +$296K | 0.08% | 173 |
|
|
2024
Q4 | $111K | Sell |
3,075
-179,345
| -98% | -$6.46M | 0.02% | 243 |
|
|
2024
Q3 | $219K | Buy |
182,420
+1,428
| +0.8% | +$1.71K | 0.04% | 213 |
|
|
2024
Q2 | $190K | Buy |
180,992
+4,954
| +3% | +$5.2K | 0.03% | 224 |
|
|
2024
Q1 | $211K | Sell |
176,038
-12,081
| -6% | -$14.5K | 0.04% | 223 |
|
|
2023
Q4 | $273K | Buy |
188,119
+20,189
| +12% | +$29.3K | 0.06% | 217 |
|
|
2023
Q3 | $267K | Sell |
167,930
-347,385
| -67% | -$552K | 0.07% | 181 |
|
|
2023
Q2 | $294K | Buy |
515,315
+66,160
| +15% | +$37.7K | 0.08% | 180 |
|
|
2023
Q1 | $198K | Buy |
449,155
+134,292
| +43% | +$59.1K | 0.06% | 195 |
|
|
2022
Q4 | $233K | Buy |
314,863
+29,585
| +10% | +$21.9K | 0.07% | 211 |
|
|
2022
Q3 | $351K | Sell |
285,278
-4,298
| -1% | -$5.29K | 0.09% | 201 |
|
|
2022
Q2 | $237K | Buy |
289,576
+82,860
| +40% | +$67.8K | 0.07% | 136 |
|
|
2022
Q1 | $314K | Buy |
206,716
+110,774
| +115% | +$168K | 0.05% | 127 |
|
|
2021
Q4 | $304K | Buy |
+95,942
| New | +$304K | 0.04% | 130 |
|